BleeqUp Showcases Revolutionary AI Cycling Glasses at Eurobike 2025
With the frame weighing less than 40g, the BleeqUp Ranger offers unparalleled protection and smart connectivity. Its features include UV400 lenses for comprehensive UV protection, an anti-fog coating for clear vision, and a durable, adjustable TR90 frame with an IP54 rating, ensuring resistance to dust and splashing water. The glasses are also prescription-compatible.
At its core, the glasses features an advanced action camera capable of recording 1080p video for up to an hour, with an extendable recording time of up to 4 hours when paired with an optional helmet battery or taillight. Its AI-powered video editing automatically highlights key moments, while immersive stabilization ensures smooth, professional-looking footage of every ride.
Communication and audio are redefined with the BleeqUp Ranger's open-ear audio system, featuring dual dynamic and xMEMS drivers for crystal-clear sound and effective wind noise cancellation. This allows for hands-free walkie-talkie use and calls, maintaining crucial situational awareness. Powered by Qualcomm's Snapdragon® W5 chipset, the glasses also offers hands-free controls and Google Maps navigation, empowering cyclists to stay safe, connected, and capture every adventure.
'We're thrilled to attend the Eurobike, a crucial event for connecting with industry leaders and passionate riders,' said Derek Wu, Founder and CEO of BleeqUp. 'With the BleeqUp Ranger, cyclists gain unprecedented peace of mind, documenting their journeys whether capturing scenic views, showcasing extreme stunts, or recording rides for safety.'
The BleeqUp Ranger first earned widespread acclaim at MWC in February 2025 for its innovative design and powerful features, which provide cyclists with a fresh and convenient experience. Its recognition continued in April when BleeqUp Ranger was honored with the Red Dot Award for Product Design 2025.
For the latest information, please visit the website here and follow us on Facebook, Instagram, and YouTube.
About BleeqUp
Founded in 2022, BleeqUp is an AI-powered outdoor sports technology startup dedicated to enhancing experiences for professional adventurers in cycling, running, mountaineering, and skiing. Through smart, stylish eyewear, BleeqUp revolutionizes outdoor pursuits by boosting performance and connectivity.
Photo – https://mma.prnewswire.com/media/2721810/The_BleeqUp_Ranger_Eurobike_2025.jpg
View original content:https://www.prnewswire.co.uk/news-releases/bleequp-showcases-revolutionary-ai-cycling-glasses-at-eurobike-2025-302494363.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
29 minutes ago
- Malaysian Reserve
Century Complete Announces New Homes Now Selling in Prescott Valley, Arizona
New single-family homes offer up to 4 bedrooms and designer-selected finishes—starting from the $370s PRESCOTT VALLEY, Ariz., July 1, 2025 /PRNewswire/ — Century Communities, Inc. (NYSE: CCS)—a top 10 national homebuilder, industry leader in online home sales, and the highest-ranked homebuilder on Newsweek's list of America's Most Trustworthy Companies 2025—is excited to announce that the Company's Century Complete brand is now selling at Point of View, a new collection of single-family homes in Prescott Valley priced from the $370s. Point of View's desirable location balances small-town charm with access to outdoor destinations, Prescott, and historic Jerome—boasting art galleries, boutique shops, and local restaurants. Learn more, explore available homes, and buy online at 'We're delivering attainable homeownership in a scenic location surrounded by abundant outdoor recreation, situated between Mingus Mountain and Prescott National Forest,' said Dave Hodgman, Executive Vice President of Field Operations. 'Homebuyers will appreciate our thoughtfully designed floor plans and streamlined online buying process. Opportunities are limited, so get in touch with our sales team today to find your best fit.' POINT OF VIEW | PRESCOTT VALLEY, AZNow selling from the $370s Single-family homes (all single-story floor plans) 3 to 4 bedrooms, 2 bathrooms, 2-bay garages 1,267 to 1,803 square feet Included features such as quartz countertops, Whirlpool® stainless-steel appliances, white cabinets, and Shaw® wood-look flooring Open-concept layouts with designer-selected finishes Prime location near Highway 89A Quick drive to Prescott and historic Jerome Easy access to outdoor recreation at Prescott National Forest and Mingus Mountain Community LocationN. Viewpoint Road and Ryder RoadPrescott Valley, AZ 86315520.213.8607 THE FREEDOM OF ONLINE HOMEBUYING Century Complete is proud to feature its industry-first online homebuying experience on all available homes in Arizona, allowing homebuyers to easily find their best fit and purchase when they're ready—all while continuing to work with their local real estate agent of choice. Homebuyers can further streamline the homebuying process by financing online with Century Complete's affiliate lender, Inspire Home Loans®. How it works: Shop homes at Click 'Buy Now' on any available home Fill out a quick Buy Online form Electronically submit an initial earnest money deposit Electronically sign a purchase contract via DocuSign® Learn more about the Buy Online experience at About Century Communities Century Communities, Inc. (NYSE: CCS) is one of the nation's largest homebuilders, an industry leader in online home sales, and one of the highest-ranked homebuilders on Newsweek's list of America's Most Trustworthy Companies 2025—consecutively awarded for a third year—and Newsweek's list of the World's Most Trustworthy Companies 2024. Through its Century Communities and Century Complete brands, Century's mission is to build attractive, high-quality homes at affordable prices to provide its valued customers with A HOME FOR EVERY DREAM®. Century is engaged in all aspects of homebuilding — including the acquisition, entitlement and development of land, along with the construction, innovative marketing and sale of quality homes designed to appeal to a wide range of homebuyers. The Company operates in 17 states and over 45 markets across the U.S., and also offers mortgage, title, insurance brokerage, and escrow services in select markets through its Inspire Home Loans, Parkway Title, IHL Home Insurance Agency, and IHL Escrow subsidiaries. To learn more about Century Communities, please visit
Malaysian Reserve
5 hours ago
- Malaysian Reserve
Zuowei Technology Shining at WHX Miami Medical Expo
SHENZHEN, China, July 1, 2025 /PRNewswire/ — From June 11 to 13, the 2025 WHX Miami Medical Expo (formerly known as FIME), the annual grand event of the medical industry in the Americas, was held at the Miami Beach Convention Center. As one of the largest and most influential professional exhibitions for medical devices and equipment in the Americas, WHX Miami attracted top companies from around the world, serving as a vital hub connecting the healthcare markets of North America, South America, and the Caribbean. Among the many exhibitors, Shenzhen Zuowei Technology Co., Ltd. from China stood out with its impressive presence. Its cutting-edge intelligent nursing robots and innovative solutions became a highlight of the expo, drawing significant attention from attendees and industry professionals alike. Zuowei Technology showcased a series of its latest Intelligent Incontinence Cleaning product at the expo, including Gait Training Electric Wheelchair, Portable Bed Shower Machine, and Foldable Electric Mobility Scooter. Among them, the Portable Bed Shower Machine stood out with its compact design and powerful functionality. Specially developed for individuals with limited mobility, this device breaks through the traditional constraints of bathing environments and labor demands. With its one-touch intelligent operation, constant temperature system, and safety-focused design, the machine makes the bathing process easy, safe, and convenient. The Gait Training Electric Wheelchair also garnered significant attention at the expo. Equipped with high-precision sensors and an intelligent navigation system, it provides stable and secure walking assistance for individuals with mobility impairments. Meanwhile, the foldable electric mobility scooter, known for its 'small size, big power,' features a lightweight, easily foldable design for effortless transport, extended battery life, and a comfortable riding experience—bringing newfound freedom of movement to users facing travel limitations. These products seamlessly integrate cutting-edge technologies such as artificial intelligence (AI) and the Internet of Things (IoT) into caregiving scenarios. They not only highlight Zuowei Technology's strong R&D capabilities in intelligent nursing solutions but also reflect the keen insight of Chinese enterprises into the evolving global care market. During the three-day exhibition, the Zuowei Technology team welcomed over 100 clients from around the world with great enthusiasm and professionalism. Among them were long-term overseas partners who have worked closely with the company for years, as well as new clients who were instantly drawn to the unique appeal of Zuowei's products upon first contact. A U.S.-based distributor shared his thoughts with the media: 'Zuowei's products are truly outstanding. I believe there will be strong demand for them in the U.S. market. We look forward to establishing a long-term partnership with Zuowei Technology to jointly promote the development of intelligent caregiving technologies.' The company's representative, in an interview with reporters, commented: 'This exhibition holds great significance for us. We see it as a key opportunity to accelerate our international expansion, actively explore global markets, and provide high-quality, efficient products and solutions to clients worldwide.' In recent years, as Chinese enterprises continue to achieve breakthroughs in core technologies and demonstrate remarkable product innovation, an increasing number of Chinese medical technology products are gaining recognition in international markets. Zuowei Technology has already established stable business relationships with partners in over 50 countries and regions worldwide, earning widespread praise and trust. Dedicated to intelligent care for the disabled elderly, Zuowei Technology focuses on six essential caregiving needs—toileting, bathing, eating, getting in and out of bed, walking, and dressing. The company provides comprehensive solutions combining intelligent nursing series and smart caregiving platforms, delivering more thoughtful, professional, and technology-driven elderly care experiences to users around the globe. Zuowei remains committed to contributing to the global senior care industry with cutting-edge innovation and heartfelt service.
Malaysian Reserve
6 hours ago
- Malaysian Reserve
Halozyme Therapeutics Added to Russell 1000® Index
SAN DIEGO, June 30, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that it has been added to the U.S. large-cap Russell 1000® Index, effective after market close on June 27th, as part of the 2025 FTSE Russell indexes annual reconstitution. The Russell 1000® Index includes approximately 1,000 of the largest U.S. securities based on market capitalization and is widely used by investors as a benchmark for the performance of large-cap stocks. 'Joining the Russell 1000 Index is an important milestone that reflects our leadership in rapid large-volume subcutaneous drug delivery and our track record of durable top-and-bottom line growth,' said Dr. Helen Torley, President and CEO of Halozyme. 'The inclusion will help to expand our visibility among the investment community as we continue to execute our strategy and deliver sustainable growth and profitability well into the future.' The Russell 1000® is managed by FTSE Russell, a global leader in index and analytics. Membership in the Russell 1000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3000® Index. About Halozyme Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. As the innovators of ENHANZE® drug delivery technology with the proprietary enzyme rHuPH20, Halozyme's commercially-validated solution is used to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. Having touched one million patient lives in post-marketing use in ten commercialized products in at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and Acumen Pharmaceuticals. Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide commercial or functional advantages such as improved convenience, reliability and tolerability, and enhanced patient comfort and adherence. The Company has two commercial proprietary products, Hylenex® and XYOSTED®, partnered commercial products and ongoing product development programs with Teva Pharmaceuticals and McDermott Laboratories Limited, an affiliate of Viatris Inc. Halozyme is headquartered in San Diego, CA and has offices in Ewing, NJ and Minnetonka, MN. Minnetonka is also the site of its operations facility. For more information visit and connect with us on LinkedIn and Twitter. Safe Harbor Statement In addition to historical information, the statements set forth above include forward-looking statements including, without limitation, statements concerning the future execution of Halozyme's strategy and delivery of future sustainable growth and profitability, the durability of Halozyme's top and bottom line growth, the possible activity, benefits and attributes of ENHANZE®, the possible method of action of ENHANZE®, its potential application to aid in the dispersion and absorption of other injected therapeutic drugs, and statements concerning certain other potential benefits of ENHANZE® including facilitating more rapid delivery of injectable medications through subcutaneous delivery and potentially lowering the treatment burden for patients. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are typically, but not always, identified through use of the words 'expect,' 'believe,' 'enable,' 'may,' 'will,' 'could,' 'intends,' 'estimate,' 'anticipate,' 'plan,' 'predict,' 'probable,' 'potential,' 'possible,' 'should,' 'continue,' and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including unexpected results in the execution of Halozyme's strategy and unexpected future financial results and top and bottom line growth,. These and other factors that may result in differences are discussed in greater detail in Halozyme's most recent Annual and Quarterly Reports filed with the Securities and Exchange Commission. Except as required by law, Halozyme undertakes no duty to update forward-looking statements to reflect events after the date of this release. Contacts: Tram BuiVP, Investor Relations and Corporate Communications609-333-7668tbui@ Sydney
